Inventor
LORNA DUFFY
Inventor
GB
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07CAcyclic or carbocyclic compounds12%
PatentTitleYear
12,466,810N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases202512,180,186Quaternary indazole glucocorticoid receptor antagonists202412,098,141Bicyclic indazole glucocorticoid receptor antagonists202412,018,001Pyrimidine cyclohexenyl glucocorticoid receptor modulators202411,787,780Quaternary indazole glucocorticoid receptor antagonists202311,655,246Aminothiazole compounds as inhibitors of CTPS1202311,542,238Pyrimidine cyclohexenyl glucocorticoid receptor modulators202311,505,547Compounds202211,505,550ADO-resistant cysteamine analogs and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to STEP PHARMA S A S (3)· patent assignee history
2022Patents assigned to HORIZON ORPHAN LLC (1)· patent assignee history
2022–2025Based in GB· patent location history
2023–2024Patents assigned to CORCEPT THERAPEUTICS INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CORCEPT THERAPEUTICS INC | 5 | 2023–2024 |
| STEP PHARMA S A S | 3 | 2022–2025 |
| HORIZON ORPHAN LLC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 9 | 2022–2025 |